Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
Yahoo/BusinessWire
Saturday, July 7, 2012 - 11:29am
tags:
Amylin, lawsuits
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In AEterna Zentaris Inc. To Contact The Firm
Yahoo/CNW Group
Saturday, July 7, 2012 - 11:29am
tags:
Aeterna Zentaris, lawsuits
Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics
Yahoo/BusinessWire
Saturday, July 7, 2012 - 11:28am
tags:
Spectrum Pharmaceuticals, Allos, M&A
Exclusive: Celgene mulls Human Genome Sciences bid - source
Reuters
Saturday, July 7, 2012 - 11:27am
tags:
Celgene, Human Genome Sciences, M&A
Vertex Pharmaceuticals (VRTX): Today's Featured Health Care Loser
The Steet
Saturday, July 7, 2012 - 11:26am
tags:
Vertex Pharmaceuticals
Incyte Corp Ltd (INCY): Today's Featured Health Care Winner
The Steet
Saturday, July 7, 2012 - 11:25am
tags:
Incyte
Chelsea shareholder urges co to explore options
Reuters
Saturday, July 7, 2012 - 11:24am
tags:
Chelsea Therapeutics
ShangPharma Surges Most In 10 Months On Acquisition Offer
Bloomberg
Saturday, July 7, 2012 - 11:23am
tags:
ShangPharma, M&A
XOMA Enrolls for Gevokizumab Trials
Yahoo/Zacks
Saturday, July 7, 2012 - 11:22am
tags:
Xoma, gevokizumab, uveitis
Amylin Deal Signals Diabetes Space is Hot
Motley Fool
Friday, July 6, 2012 - 7:34pm
tags:
diabetes, Amylin, M&A, Bristol-Myers Squibb, AstraZeneca
Bristol-Myers Gets U.S. Approval For Wider Erbitux Use
Bloomberg
Friday, July 6, 2012 - 7:21pm
tags:
Bristol-Myers Squibb, colorectal cancer, Eli Lilly, Erbitux
Pfizer sued by retailers for generic Lipitor delay
Reuters
Friday, July 6, 2012 - 12:53pm
tags:
generics, Lipitor, Pfizer
U.S. court denies Sequenom's motion against Ariosa
Reuters
Friday, July 6, 2012 - 12:50pm
tags:
Ariosa, Sequenom, MaterniT21
How to Tell When A Drug Company Fibs About Clinical Trial Results
TheStreet.com
Friday, July 6, 2012 - 12:49pm
tags:
Osiris, clinical trials
Why the Street Should Love ViroPharma's Earnings
Motley Fool
Friday, July 6, 2012 - 12:47pm
tags:
ViroPharma, earnings
An Assault On Vertex, Enthusiasm Building Around Xoma
Seeking Alpha
Friday, July 6, 2012 - 12:46pm
tags:
Xoma, Vertex
Seven pharma companies partner with Gates Foundation to speed TB drug discovery
Yahoo/Fly on the Wall
Friday, July 6, 2012 - 12:45pm
tags:
tuberculosis, Bill Gates, Abbott Laboratories, AstraZeneca, Bayer, Eli Lilly, GSK, Merck, Sanofi
Settlement unveils fed's leash on Glaxo manufacturing
Fierce Pharma Manufacturing
Friday, July 6, 2012 - 11:22am
tags:
GSK, drug manufacturing
NICE turns down Avastin for breast cancer
Fierce Pharma
Friday, July 6, 2012 - 11:20am
tags:
Avastin, Roche, breast cancer, NICE, UK
K-V says it will go bankrupt without FDA intervention
Fierce Pharma
Friday, July 6, 2012 - 11:19am
tags:
KV Pharmaceutical, FDA, Makena

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.